Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Climb Global Solutions
CLMB
$508M
| $202K | ﹤0.01% |
18,828
+3,616
| +24% | +$39.9K |
|
|
PLM
3177
DELISTED
PolyMet Mining Corp.
PLM
| $202K | ﹤0.01% |
97,053
+20,527
| +27% | +$42.5K |
|
3178
Invesco Mortgage Capital
IVR
$757M
| $201K | ﹤0.01% |
20,113
-151,891
| -88% | -$1.68M |
|
3179
Theravance Biopharma
TBPH
$874M
| $201K | ﹤0.01% |
23,269
-5,554
| -19% | -$53.6K |
|
3180
Zegna
ZGN
$4.09B
| $201K | ﹤0.01% |
14,404
-3,257
| -18% | -$47.5K |
|
|
GPMT
3181
Granite Point Mortgage Trust
GPMT
$69.5M
| $200K | ﹤0.01% |
41,079
+29,848
| +266% | +$160K |
|
3182
Ouster
OUST
$2.86B
| $200K | ﹤0.01% |
+39,766
| New | +$220K |
|
3183
Cooper-Standard Automotive
CPS
$538M
| $200K | ﹤0.01% |
14,911
+9,642
| +183% | +$153K |
|
3184
Riskified
RSKD
$698M
| $200K | ﹤0.01% |
44,607
+10,097
| +29% | +$46.5K |
|
3185
Limbach Holdings
LMB
$873M
| $200K | ﹤0.01% |
6,298
+65
| +1% | +$1.97K |
|
3186
Treace Medical Concepts
TMCI
$304M
| $199K | ﹤0.01% |
16,340
-2,934
| -15% | -$53.7K |
|
3187
Shinhan Financial Group
SHG
$33.4B
| $199K | ﹤0.01% |
7,500
| – | – |
|
3188
AdvisorShares Pure US Cannabis ETF
MSOS
$846M
| $199K | ﹤0.01% |
25,000
| – | – |
|
3189
FRP Holdings
FRPH
$432M
| $198K | ﹤0.01% |
7,322
-490
| -6% | -$13.8K |
|
3190
Sumitomo Mitsui Financial
SMFG
$160B
| $197K | ﹤0.01% |
+20,000
| New | +$185K |
|
3191
Xeris Biopharma Holdings
XERS
$1.4B
| $197K | ﹤0.01% |
105,743
+13,040
| +14% | +$29.9K |
|
|
SWI
3192
DELISTED
SolarWinds Corporation Common Stock
SWI
| $197K | ﹤0.01% |
20,820
+1,842
| +10% | +$19.3K |
|
|
BHR
3193
Braemar Hotels & Resorts
BHR
$148M
| $196K | ﹤0.01% |
70,827
+16,096
| +29% | +$50K |
|
3194
York Water
YORW
$499M
| $196K | ﹤0.01% |
5,230
-304
| -5% | -$12.4K |
|
3195
LifeVantage
LFVN
$83M
| $196K | ﹤0.01% |
30,358
| – | – |
|
3196
Forestar Group
FOR
$1.47B
| $196K | ﹤0.01% |
7,263
+23
| +0.3% | +$634 |
|
3197
MainStreet Bancshares
MNSB
$166M
| $195K | ﹤0.01% |
9,517
+2,025
| +27% | +$46.3K |
|
3198
Jakks Pacific
JAKK
$298M
| $195K | ﹤0.01% |
10,485
+7,729
| +280% | +$148K |
|
3199
American Superconductor
AMSC
$1.5B
| $193K | ﹤0.01% |
25,608
+25,604
| +640,100% | +$213K |
|
3200
Community Health Systems
CYH
$412M
| $193K | ﹤0.01% |
66,460
-9,669
| -13% | -$35.8K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.